Elily任命Lucas Montarce为首席财务官,以满足对糖尿病和减肥药物日益增长的需求。 Eli Lilly appoints Lucas Montarce as CFO to meet rising demand for diabetes and weight loss drugs.

Elilly已任命Lucas Montarce为财务主任,在Anat Ashkenazi离开后立即生效。 Eli Lilly has appointed Lucas Montarce as Chief Financial Officer, effective immediately, following the departure of Anat Ashkenazi. Montarce是2001年以来的公司老兵,以前曾担任全球主计长的高级副总裁。 Montarce, a company veteran since 2001, previously served as Senior VP of Global Controller. 莉莉在扩大制造业以满足对糖尿病和减肥药物日益增长的需求方面投入了大量资金, His appointment comes as Lilly invests significantly in expanding its manufacturing to meet rising demand for diabetes and weight loss drugs. 分析家预测,到2030年代初,这些药品的市场可能超过1 500亿美元。 Analysts predict the market for such medications could exceed $150 billion by the early 2030s.

September 09, 2024

14 文章